Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-01

Clinical Trial Update: Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder [NA]

View source ↗

Summary

This update notes a completed clinical trial examining microbiome-targeted strategies for improving outcomes in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Melvin McInnis, MD | Conditions: Bipolar Disorder | NA | Status: COMPLETED